From: Constructing an assessment framework for the quality of asthma smartphone applications
Dimensions | |
 | 1. Goals and planning |
 | 2. Feedback and monitoring |
 | 3. Shaping knowledge |
 | 4. Social support |
 | 5. Reward and threat |
 | 6. Natural consequences |
 | 7. Improving the compliance |
 | 8. Asthma information |
 | 9. Patient skills training |
 | 10. Non-pharmacological interventions |
Sub- dimensions | 1.1 Goal setting (outcome/behavior) |
 | 1.2 Asthma action plans |
 | 2.1 Self-monitoring of behavior |
 | 2.2 Self-monitoring of outcomes of behavior |
 | 2.3 Feedback |
 | 3.1 Demonstration of the behavior |
 | 3.2 Behavior substitution |
 | 4.1 Practical social support |
 | 4.2 Emotional support |
 | 5.1 Social reward |
 | 5.2 Threat |
 | 6.1 Information about health consequences |
 | 6.2 Salience of consequences |
 | 7.1 Prompts |
 | 7.2 Regulation |
 | 8.1 The nature of asthma |
 | 8.2 Asthma medication |
 | 8.3 Management of asthma exacerbation |
 | 8.4 Management of comorbidities |
 | 9.1 Peak flow meter usage |
 | 9.2 Inhaler technique |
 | 10.1 Identifying and avoiding risk factors |
 | 10.2 Good life style |
Items | 1.1.1 Ask patients to reflect on what they would consider as good asthma control |
 | 1.1.2 The purpose of asthma control is to have good asthma control and no limited activities |
 | 1.1.3 Set specific behavior goals in terms of the behavior to be achieved |
 | 1.1.4 State the factors that influence the behavior, and generate strategies that overcome barriers and increase facilitators |
 | 1.1.5 Set goals in terms of a positive outcome |
 | 1.1.6 Re-set new goals in light of achievement |
 | 1.2.1 Patient should be provided with an asthma action plan, and updated in time |
 | 1.2.2 State that asthma action plan helps patient to recognize and response appropriately to worsening asthma |
 | 1.2.3 Set detailed planning of performance of the behavior |
 | 1.2.4 Patients need to affirm commitment to change the behavior |
 | 2.1.1 States that the valid approaches for self-monitoring are PEF monitoring and symptom recognition |
 | 2.1.2 Provides reminders to monitor PEF everyday, and can record details |
 | 2.1.3 Provides reminders to monitor symptoms everyday, and can record details |
 | 2.1.4 Provides a diary to record medication |
 | 2.1.5 Provides a diary to record patients’ feeling |
 | 2.1.5 Provides a diary to record return visit |
 | 2.2.1 Provides a diary to record lung function test |
 | 2.2.2 Provides a diary to record worsening asthma-related events |
 | 2.2.3 Provides a diary to record factors related to worsening asthma, such as weather |
 | 2.2.4 Provides asthma assessment tools |
 | 2.3.1 Monitors and provides informative or evaluative feedback on performance of the behavior |
 | 2.3.2 Provide professional feedback information based on patients’ inhaler technique |
 | 2.3.3 Provides evaluative feedback on asthma status |
 | 2.3.4 Provides informative feedback on asthma severity based on PEF values |
 | 2.3.5 Generates PEF/symptoms summary visualization |
 | 2.3.6 Provides result feedback through connecting medical devices |
 | 3.1.1 Provide video tutorials or animations of peak flow meter use |
 | 3.1.2 Provide video tutorials or animations of inhaler devices use |
 | 3.1.3 Provides video tutorials or animations to display instructions of spacer for patients |
 | 3.2.1 States wanted or neutral behavior to substitute the unwanted behavior |
 | 3.2.2 States repetition of the wanted behavior |
 | 4.1.1 Allows establishing a cooperative relationship between doctors and patients |
 | 4.1.2 Allows setting goals by patients and doctors |
 | 4.1.3 Provides video tutorials or animations about asthma information introduced by medical workers |
 | 4.1.4 Allows users to share health data with medical workers through email |
 | 4.1.5 Allows patients to communicate with patients with controlled asthma |
 | 4.2.1 States that friends, relatives and medical workers should provide emotional support |
 | 4.2.2 Provides encouragement and consultation from friends, relatives and medical workers |
 | 4.2.3 Provides self-incentive in performing the behavior |
 | 5.1.1 Send incentive information if there has been progress in performing the behavior |
 | 5.2.1 Do not send incentive information if patients with unwanted behavior |
 | 6.1.1 Provides information about health consequences of performing the behavior |
 | 6.1.2 Provides information about social and environmental consequences of performing the behavior |
 | 6.2.1 Provides methods specifically designed to emphasize the consequences of performing the behavior |
 | 7.1.1 Set environmental or social stimulus in order to prompt the behavior |
 | 7.1.2 Allows users to set reminder for medication/return visit |
 | 7.1.3 Provides reminders for checking inhaler to ensure inhalers are not empty |
 | 7.1.4 Provides reminders for checking inhaler to ensure inhalers are in date |
 | 7.2.1 Provides stress-reduction strategies to prevent symptoms from worsening |
 | 7.2.2 States the importance of avoiding use of multiple different inhaler types |
 | 8.1.1 Asthma is a chronic respiratory disease, together with airway hyperresponsiveness and airway inflammation |
 | 8.1.2 Asthma is caused by a combination of endogenous (genetic) and external (environment) causes. |
 | 8.1.3 Respiratory symptoms of asthma are wheeze, shortness of breath, chest tightness and cough |
 | 8.1.4 Asthma severity can be assessed as mild asthma, moderate asthma, and severe asthma |
 | 8.1.5 Asthma cannot be cured, but can be effectively controlled through effective management. |
 | 8.1.6 Early controller treatment of asthma is critical to achieving optimal outcomes |
 | 8.2.1 Asthma medications include controller medications and reliever medications |
 | 8.2.2 Controller medications can be used to reduce airway inflammation, control symptoms, and reduce future risks |
 | 8.2.3 Controller medications should be used for regular |
 | 8.2.4 Reliever medications are used to relief breakthrough symptoms |
 | 8.2.5 Reliever medications are used as needed |
 | 8.2.6 Local side-effects of ICS include oral thrush and dysphonia |
 | 8.2.7 Side-effects of oral corticosteroids include osteoporosis, hypertension, and diabetes, etc. |
 | 8.2.8 Side-effects of ß2-agoinsts include tachycardia and tremor |
 | 8.2.9 Patients need to carry asthma reliever medications (such as Ventolin solution) with them in case of emergency |
 | 8.3.1 Early signs and symptoms of worsening asthma are sneezing, runny nose, dry cough, shortness of breath, and chest tightness, etc. |
 | 8.3.2 Symptoms of asthma exacerbations are a progressive increase in symptoms of shortness of breath, cough, wheezing or chest tightness |
 | 8.3.3 It is important to adjust treatment plan and went to see the doctor in time |
 | 8.3.4 Patients were removed from the allergen environment, inhale ß2 agonist, and went to see the doctor in time |
 | 8.4.1 Complications should be treated, such as rhinitis, sinusitis, and symptomatic gastroesophageal reflux disease |
 | 8.4.2 Obese patient should lose weight |
 | 9.1.1 Operational criteria of peak expiratory flow meter: taking a deep breath; sealing your mouth tightly around the mouthpiece; blowing as hard and as fast as you soon; checking the number, re-setting the pointer to zero; and repeating two more times |
 | 9.1.2 A peak flow meter is used for monitoring lung function changes in patients |
 | 9.1.3 Patients should use the same meter each time |
 | 9.2.1 Patients should be encouraged to participate in the choice of inhaler device |
 | 9.2.2 Emphasizes the importance of correct inhaler technique |
 | 9.2.3 States that patients should breathe deeply and hold their breath for a few seconds for effective use of inhaler devices |
 | 9.2.4 Patients should rinse and spit the mouse after using the inhaled hormone |
 | 9.2.5 States that appropriate use of spacer device can improve effect and reduce adverse drug reactions |
 | 10.1.1 States identifying risk factors that make asthma worse |
 | 10.1.2 States the importance of avoidance of environmental smoke exposure |
 | 10.1.3 States the importance of avoidance of occupational exposures |
 | 10.1.4 States the importance of avoidance of medications that may make asthma worse |
 | 10.1.5 States the importance of avoidance of allergens exposure |
 | 10.2.1 States the importance of consuming a diet high in fruit and vegetables |
 | 10.2.2 States the importance of avoidance of indoor air pollutants |
 | 10.2.3 States the importance of engaging in regular physical activity |